

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.46903116 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.46903116 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.06705673 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.06705673 |
| 5 | * aromatic amino acid family catabolic process (GO:0009074) | 6.89148294 |
| 6 | * indole-containing compound catabolic process (GO:0042436) | 6.33149000 |
| 7 | * indolalkylamine catabolic process (GO:0046218) | 6.33149000 |
| 8 | * tryptophan catabolic process (GO:0006569) | 6.33149000 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.07372505 |
| 10 | * kynurenine metabolic process (GO:0070189) | 6.01559907 |
| 11 | bile acid biosynthetic process (GO:0006699) | 6.00729407 |
| 12 | * tryptophan metabolic process (GO:0006568) | 5.90722731 |
| 13 | urea metabolic process (GO:0019627) | 5.71420889 |
| 14 | urea cycle (GO:0000050) | 5.71420889 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.66744300 |
| 16 | complement activation, alternative pathway (GO:0006957) | 5.51897300 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.40903370 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.39197692 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.38679931 |
| 20 | regulation of protein activation cascade (GO:2000257) | 5.35929574 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.33387824 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.32733356 |
| 23 | protein carboxylation (GO:0018214) | 5.32733356 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.25053814 |
| 25 | cysteine metabolic process (GO:0006534) | 5.17629704 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.11713515 |
| 27 | bile acid metabolic process (GO:0008206) | 5.02892926 |
| 28 | regulation of complement activation (GO:0030449) | 5.02437610 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.93589633 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.93321381 |
| 31 | cellular response to ethanol (GO:0071361) | 4.91677543 |
| 32 | * aromatic amino acid family metabolic process (GO:0009072) | 4.88060453 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.84492864 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.79436037 |
| 35 | tyrosine metabolic process (GO:0006570) | 4.74393324 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.72994444 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.68180115 |
| 38 | plasma lipoprotein particle remodeling (GO:0034369) | 4.68068211 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.68068211 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.68068211 |
| 41 | phospholipid efflux (GO:0033700) | 4.56364429 |
| 42 | * alpha-amino acid catabolic process (GO:1901606) | 4.49774610 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.46115871 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.46115871 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.44059719 |
| 46 | negative regulation of sterol transport (GO:0032372) | 4.41453987 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.41453987 |
| 48 | coenzyme catabolic process (GO:0009109) | 4.36799087 |
| 49 | imidazole-containing compound metabolic process (GO:0052803) | 4.36154678 |
| 50 | * indolalkylamine metabolic process (GO:0006586) | 4.36021473 |
| 51 | bile acid and bile salt transport (GO:0015721) | 4.35108810 |
| 52 | lysine catabolic process (GO:0006554) | 4.34033687 |
| 53 | lysine metabolic process (GO:0006553) | 4.34033687 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 4.31380646 |
| 55 | * cellular biogenic amine catabolic process (GO:0042402) | 4.30560302 |
| 56 | * amine catabolic process (GO:0009310) | 4.30560302 |
| 57 | aldehyde catabolic process (GO:0046185) | 4.21845085 |
| 58 | cellular glucuronidation (GO:0052695) | 4.20137475 |
| 59 | cholesterol efflux (GO:0033344) | 4.16584248 |
| 60 | glycine metabolic process (GO:0006544) | 4.14781826 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.14692757 |
| 62 | low-density lipoprotein particle remodeling (GO:0034374) | 4.11727627 |
| 63 | * cellular amino acid catabolic process (GO:0009063) | 4.09513776 |
| 64 | positive regulation of heat generation (GO:0031652) | 4.09422148 |
| 65 | glutamate metabolic process (GO:0006536) | 4.04763226 |
| 66 | ethanol oxidation (GO:0006069) | 4.04016594 |
| 67 | fibrinolysis (GO:0042730) | 4.01833891 |
| 68 | arginine metabolic process (GO:0006525) | 3.98310272 |
| 69 | serine family amino acid metabolic process (GO:0009069) | 3.96075850 |
| 70 | * benzene-containing compound metabolic process (GO:0042537) | 3.94833944 |
| 71 | blood coagulation, intrinsic pathway (GO:0007597) | 3.91395896 |
| 72 | glucuronate metabolic process (GO:0019585) | 3.85521224 |
| 73 | uronic acid metabolic process (GO:0006063) | 3.85521224 |
| 74 | complement activation, classical pathway (GO:0006958) | 3.84573533 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 3.82731319 |
| 76 | signal peptide processing (GO:0006465) | 3.82486713 |
| 77 | cofactor catabolic process (GO:0051187) | 3.82441082 |
| 78 | protein activation cascade (GO:0072376) | 3.81714992 |
| 79 | phospholipid homeostasis (GO:0055091) | 3.79935476 |
| 80 | complement activation (GO:0006956) | 3.79760845 |
| 81 | cytolysis (GO:0019835) | 3.78448303 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 3.74955790 |
| 83 | regulation of establishment of cell polarity (GO:2000114) | 3.71436809 |
| 84 | negative regulation of interleukin-12 production (GO:0032695) | 3.69196521 |
| 85 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.66613223 |
| 86 | positive regulation of lipid catabolic process (GO:0050996) | 3.66030847 |
| 87 | * NAD biosynthetic process (GO:0009435) | 3.66007977 |
| 88 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65046221 |
| 89 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65046221 |
| 90 | drug catabolic process (GO:0042737) | 3.64829594 |
| 91 | * cellular modified amino acid catabolic process (GO:0042219) | 3.63754962 |
| 92 | * dicarboxylic acid biosynthetic process (GO:0043650) | 3.61812079 |
| 93 | opsonization (GO:0008228) | 3.60747131 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.59993757 |
| 95 | acute-phase response (GO:0006953) | 3.59656044 |
| 96 | negative regulation of lipase activity (GO:0060192) | 3.58104795 |
| 97 | ketone body metabolic process (GO:1902224) | 3.57463818 |
| 98 | * organic acid catabolic process (GO:0016054) | 3.57330896 |
| 99 | * carboxylic acid catabolic process (GO:0046395) | 3.57330896 |
| 100 | regulation of bile acid biosynthetic process (GO:0070857) | 3.56825798 |
| 101 | plasma lipoprotein particle organization (GO:0071827) | 3.55970724 |
| 102 | * nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55398180 |
| 103 | * pyridine nucleotide biosynthetic process (GO:0019363) | 3.55398180 |
| 104 | sterol homeostasis (GO:0055092) | 3.53944631 |
| 105 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.51040748 |
| 106 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.48089968 |
| 107 | short-chain fatty acid metabolic process (GO:0046459) | 3.47755436 |
| 108 | sphingoid metabolic process (GO:0046519) | 3.28417655 |
| 109 | positive regulation of developmental pigmentation (GO:0048087) | 3.26567253 |
| 110 | lipid translocation (GO:0034204) | 3.25894324 |
| 111 | phospholipid translocation (GO:0045332) | 3.25894324 |
| 112 | regulation of heat generation (GO:0031650) | 3.23143028 |
| 113 | snRNA transcription (GO:0009301) | 3.22543744 |
| 114 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.21917923 |
| 115 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.21764412 |
| 116 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.16607158 |
| 117 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.12019416 |
| 118 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.10007855 |
| 119 | protein K48-linked deubiquitination (GO:0071108) | 3.07784109 |
| 120 | regulation of memory T cell differentiation (GO:0043380) | 3.06656517 |
| 121 | negative regulation of mast cell activation (GO:0033004) | 3.03193883 |
| 122 | iron ion import (GO:0097286) | 2.99311312 |
| 123 | positive regulation of defense response to virus by host (GO:0002230) | 2.98253450 |
| 124 | regulation of interferon-alpha production (GO:0032647) | 2.98187216 |
| 125 | cellular response to ATP (GO:0071318) | 2.97268615 |
| 126 | response to peptidoglycan (GO:0032494) | 2.96420910 |
| 127 | T-helper 1 type immune response (GO:0042088) | 2.93958954 |
| 128 | superoxide anion generation (GO:0042554) | 2.90314190 |
| 129 | cellular response to exogenous dsRNA (GO:0071360) | 2.87079347 |
| 130 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.87046029 |
| 131 | flavonoid metabolic process (GO:0009812) | 2.85992724 |
| 132 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.84304505 |
| 133 | striated muscle atrophy (GO:0014891) | 2.82532251 |
| 134 | regulation of pigment cell differentiation (GO:0050932) | 2.82398619 |
| 135 | macrophage activation involved in immune response (GO:0002281) | 2.81566170 |
| 136 | response to type I interferon (GO:0034340) | 2.81486921 |
| 137 | regulation of hippo signaling (GO:0035330) | 2.81137074 |
| 138 | endosome to melanosome transport (GO:0035646) | 2.80771973 |
| 139 | endosome to pigment granule transport (GO:0043485) | 2.80771973 |
| 140 | detection of molecule of bacterial origin (GO:0032490) | 2.79692899 |
| 141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79294097 |
| 142 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.77938612 |
| 143 | regulation of vitamin metabolic process (GO:0030656) | 2.77130292 |
| 144 | protein K63-linked deubiquitination (GO:0070536) | 2.74617496 |
| 145 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.73925778 |
| 146 | type I interferon signaling pathway (GO:0060337) | 2.70967353 |
| 147 | cellular response to type I interferon (GO:0071357) | 2.70967353 |
| 148 | regulation of fever generation (GO:0031620) | 2.70238169 |
| 149 | regulation of interleukin-12 production (GO:0032655) | 2.70176084 |
| 150 | positive regulation of interleukin-12 production (GO:0032735) | 2.69767734 |
| 151 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.69176910 |
| 152 | regulation of chronic inflammatory response (GO:0002676) | 2.68241088 |
| 153 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.68205453 |
| 154 | cytokine biosynthetic process (GO:0042089) | 2.66860737 |
| 155 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.65194748 |
| 156 | detection of light stimulus involved in visual perception (GO:0050908) | 2.65194748 |
| 157 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65169844 |
| 158 | positive regulation of interferon-alpha production (GO:0032727) | 2.63630078 |
| 159 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.63440129 |
| 160 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.63309163 |
| 161 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63136548 |
| 162 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62425461 |
| 163 | establishment of protein localization to vacuole (GO:0072666) | 2.62178434 |
| 164 | protein targeting to vacuole (GO:0006623) | 2.62178434 |
| 165 | protein targeting to lysosome (GO:0006622) | 2.62178434 |
| 166 | positive regulation of natural killer cell activation (GO:0032816) | 2.60808003 |
| 167 | regulation of mononuclear cell migration (GO:0071675) | 2.59685266 |
| 168 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.58504887 |
| 169 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.56226198 |
| 170 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.55558955 |
| 171 | positive regulation of type 2 immune response (GO:0002830) | 2.54968806 |
| 172 | negative regulation of lipid storage (GO:0010888) | 2.51898670 |
| 173 | cellular extravasation (GO:0045123) | 2.47683228 |
| 174 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.47083388 |
| 175 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.44145703 |
| 176 | protein K11-linked deubiquitination (GO:0035871) | 2.43803257 |
| 177 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.43730085 |
| 178 | intracellular pH reduction (GO:0051452) | 2.43680980 |
| 179 | regulation of mast cell activation (GO:0033003) | 2.43229571 |
| 180 | cytokine metabolic process (GO:0042107) | 2.41541978 |
| 181 | skeletal muscle adaptation (GO:0043501) | 2.40695599 |
| 182 | regulation of gamma-delta T cell activation (GO:0046643) | 2.40323939 |
| 183 | sphingosine metabolic process (GO:0006670) | 2.37963844 |
| 184 | neural tube formation (GO:0001841) | 2.37817951 |
| 185 | reactive oxygen species biosynthetic process (GO:1903409) | 2.37233756 |
| 186 | positive regulation of antigen processing and presentation (GO:0002579) | 2.37172348 |
| 187 | establishment of protein localization to Golgi (GO:0072600) | 2.37100978 |
| 188 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.36283024 |
| 189 | * indole-containing compound metabolic process (GO:0042430) | 2.34652285 |
| 190 | germinal center formation (GO:0002467) | 2.34160563 |
| 191 | muscle atrophy (GO:0014889) | 2.31592377 |
| 192 | response to protozoan (GO:0001562) | 2.30893698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.88087119 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.14257914 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.75687062 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.18469490 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.07540354 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.79840546 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.10584011 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.79628225 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.79612077 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.59028972 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.49947562 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.49298777 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.29952707 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.26698649 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.23589642 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.16458953 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14447441 |
| 18 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1856981 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.96085150 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92785655 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88924688 |
| 22 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.81974400 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76152990 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74107596 |
| 25 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.73693059 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.72336545 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71172356 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68618102 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68600902 |
| 30 | STAT3_23295773_ChIP-Seq_U87_Human | 1.68019981 |
| 31 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.66308448 |
| 32 | TP53_16413492_ChIP-PET_HCT116_Human | 1.64504666 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63806770 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.63409929 |
| 35 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61502734 |
| 36 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.60679300 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56387007 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51674322 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50934270 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48559761 |
| 41 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.46953599 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45935427 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.43637144 |
| 44 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42503442 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.42393647 |
| 46 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40541051 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.39002182 |
| 48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38396706 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36881763 |
| 50 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.36265258 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35614280 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34176302 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.33959951 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32366322 |
| 55 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.32259161 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.32259161 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31864367 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31271259 |
| 59 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29083114 |
| 60 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.28331524 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26411182 |
| 62 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.25896311 |
| 63 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25106670 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24213328 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22628056 |
| 66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22262654 |
| 67 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22262654 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21062279 |
| 69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19695583 |
| 70 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18947321 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16755081 |
| 72 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16539974 |
| 73 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.15955480 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15353637 |
| 75 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15325616 |
| 76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13337965 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13095168 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12640381 |
| 79 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11981357 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11901649 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11853659 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10760787 |
| 83 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10141642 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09395620 |
| 85 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09191080 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08183888 |
| 87 | EWS_26573619_Chip-Seq_HEK293_Human | 1.05599087 |
| 88 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.05473543 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05437504 |
| 90 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04392019 |
| 91 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.02611787 |
| 92 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02160569 |
| 93 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02025017 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01826840 |
| 95 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01701891 |
| 96 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00766992 |
| 97 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00030063 |
| 98 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.99514685 |
| 99 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99201447 |
| 100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93483983 |
| 101 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.93098676 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90961979 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86115071 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86115071 |
| 105 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.84469151 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81194999 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81099902 |
| 108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.79641735 |
| 109 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.77972463 |
| 110 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76385470 |
| 111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75196252 |
| 112 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74295868 |
| 113 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.72653261 |
| 114 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.72164144 |
| 115 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71824530 |
| 116 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.70513636 |
| 117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68252248 |
| 118 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.66899964 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64324573 |
| 120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64289080 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.63639494 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62867173 |
| 123 | * TAF15_26573619_Chip-Seq_HEK293_Human | 0.62810072 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.61296451 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.61171501 |
| 126 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.60323377 |
| 127 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60092855 |
| 128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.59573230 |
| 129 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.59401304 |
| 130 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.59088452 |
| 131 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57725188 |
| 132 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.55593684 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55544140 |
| 134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.54413574 |
| 135 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.54348898 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53176942 |
| 137 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.52937883 |
| 138 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.51994335 |
| 139 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51253488 |
| 140 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.51213047 |
| 141 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51031636 |
| 142 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50206712 |
| 143 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.50186894 |
| 144 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.50094847 |
| 145 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.49983709 |
| 146 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49839741 |
| 147 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48603571 |
| 148 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.48582878 |
| 149 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47619886 |
| 150 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.47521116 |
| 151 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.47174623 |
| 152 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.47080173 |
| 153 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45416966 |
| 154 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.45401241 |
| 155 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.44786941 |
| 156 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43610102 |
| 157 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.43304791 |
| 158 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.42547652 |
| 159 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41640686 |
| 160 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.41438488 |
| 161 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.40513575 |
| 162 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40044113 |
| 163 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.39964811 |
| 164 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.39850893 |
| 165 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.39684691 |
| 166 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39665742 |
| 167 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.39551772 |
| 168 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39290014 |
| 169 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39105271 |
| 170 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.38806157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.04257313 |
| 2 | MP0005360_urolithiasis | 7.31121627 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.30457566 |
| 4 | MP0005365_abnormal_bile_salt | 5.94634259 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.74442176 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.03626526 |
| 7 | MP0003252_abnormal_bile_duct | 3.89250472 |
| 8 | MP0000569_abnormal_digit_pigmentation | 3.73893972 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.40351174 |
| 10 | MP0009840_abnormal_foam_cell | 3.09418051 |
| 11 | MP0003303_peritoneal_inflammation | 2.99412533 |
| 12 | MP0003646_muscle_fatigue | 2.94967278 |
| 13 | MP0005083_abnormal_biliary_tract | 2.89375782 |
| 14 | MP0003195_calcinosis | 2.83740165 |
| 15 | MP0008057_abnormal_DNA_replication | 2.73672427 |
| 16 | MP0005332_abnormal_amino_acid | 2.66750698 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 2.50562268 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.46588483 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.42382637 |
| 20 | MP0005310_abnormal_salivary_gland | 2.34747433 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.29276960 |
| 22 | MP0005671_abnormal_response_to | 2.14942795 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.13097175 |
| 24 | MP0000609_abnormal_liver_physiology | 2.12428851 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 2.01767035 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.95797352 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.91810996 |
| 28 | MP0006054_spinal_hemorrhage | 1.88737462 |
| 29 | MP0000371_diluted_coat_color | 1.84407528 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.82908359 |
| 31 | MP0000383_abnormal_hair_follicle | 1.82727176 |
| 32 | MP0003868_abnormal_feces_composition | 1.81447464 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.77729619 |
| 34 | MP0004043_abnormal_pH_regulation | 1.75152330 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.75127136 |
| 36 | MP0003045_fibrosis | 1.73048899 |
| 37 | MP0001764_abnormal_homeostasis | 1.67714821 |
| 38 | MP0004510_myositis | 1.65735514 |
| 39 | MP0009697_abnormal_copulation | 1.60317616 |
| 40 | MP0005451_abnormal_body_composition | 1.59716903 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57012524 |
| 42 | MP0000427_abnormal_hair_cycle | 1.44724192 |
| 43 | MP0009764_decreased_sensitivity_to | 1.43290012 |
| 44 | MP0003011_delayed_dark_adaptation | 1.40089435 |
| 45 | MP0009046_muscle_twitch | 1.38820682 |
| 46 | MP0002254_reproductive_system_inflammat | 1.38784596 |
| 47 | MP0003186_abnormal_redox_activity | 1.36317036 |
| 48 | MP0001819_abnormal_immune_cell | 1.30002201 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.28932806 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.26834628 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.23960827 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.23150950 |
| 53 | MP0010678_abnormal_skin_adnexa | 1.21672729 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.21301142 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.20897845 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.20313358 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.19012590 |
| 58 | MP0005647_abnormal_sex_gland | 1.17763352 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.17546685 |
| 60 | MP0008469_abnormal_protein_level | 1.16139676 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.15356099 |
| 62 | MP0000598_abnormal_liver_morphology | 1.14369902 |
| 63 | MP0009763_increased_sensitivity_to | 1.13668575 |
| 64 | MP0002405_respiratory_system_inflammati | 1.13598071 |
| 65 | MP0000604_amyloidosis | 1.12630865 |
| 66 | MP0002876_abnormal_thyroid_physiology | 1.10215264 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.09435153 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.09435153 |
| 69 | MP0000343_altered_response_to | 1.07994814 |
| 70 | MP0001873_stomach_inflammation | 1.03606887 |
| 71 | MP0009278_abnormal_bone_marrow | 1.03604700 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.97252286 |
| 73 | MP0010386_abnormal_urinary_bladder | 0.96988470 |
| 74 | MP0003436_decreased_susceptibility_to | 0.96156474 |
| 75 | MP0001835_abnormal_antigen_presentation | 0.91631125 |
| 76 | MP0002693_abnormal_pancreas_physiology | 0.91412506 |
| 77 | MP0003633_abnormal_nervous_system | 0.90275660 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 0.89901275 |
| 79 | MP0003724_increased_susceptibility_to | 0.88885661 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.88615948 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 0.87836524 |
| 82 | MP0000716_abnormal_immune_system | 0.86546657 |
| 83 | MP0005410_abnormal_fertilization | 0.86183422 |
| 84 | MP0006082_CNS_inflammation | 0.85606590 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 0.85589371 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.83849559 |
| 87 | MP0009785_altered_susceptibility_to | 0.83361314 |
| 88 | MP0001661_extended_life_span | 0.82611643 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.82162278 |
| 90 | MP0005408_hypopigmentation | 0.81453576 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.81304707 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.78773778 |
| 93 | MP0005535_abnormal_body_temperature | 0.78701030 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.75940321 |
| 95 | MP0005646_abnormal_pituitary_gland | 0.75933046 |
| 96 | MP0003690_abnormal_glial_cell | 0.75912826 |
| 97 | MP0008004_abnormal_stomach_pH | 0.73538520 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.73456043 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.72831182 |
| 100 | MP0001968_abnormal_touch/_nociception | 0.71813400 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.71533523 |
| 102 | MP0001853_heart_inflammation | 0.71194582 |
| 103 | MP0002971_abnormal_brown_adipose | 0.69474688 |
| 104 | MP0003879_abnormal_hair_cell | 0.69340136 |
| 105 | MP0005334_abnormal_fat_pad | 0.67820001 |
| 106 | MP0004381_abnormal_hair_follicle | 0.66555521 |
| 107 | MP0002090_abnormal_vision | 0.66429484 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.66153033 |
| 109 | MP0005670_abnormal_white_adipose | 0.64970198 |
| 110 | MP0004233_abnormal_muscle_weight | 0.64679143 |
| 111 | MP0003631_nervous_system_phenotype | 0.64490228 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.64436954 |
| 113 | MP0002736_abnormal_nociception_after | 0.64241591 |
| 114 | MP0005025_abnormal_response_to | 0.62277243 |
| 115 | MP0000685_abnormal_immune_system | 0.62095527 |
| 116 | MP0002419_abnormal_innate_immunity | 0.60700241 |
| 117 | MP0005220_abnormal_exocrine_pancreas | 0.60443241 |
| 118 | MP0001845_abnormal_inflammatory_respons | 0.59278584 |
| 119 | MP0005266_abnormal_metabolism | 0.56159375 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.54573690 |
| 121 | MP0001790_abnormal_immune_system | 0.54086182 |
| 122 | MP0005387_immune_system_phenotype | 0.54086182 |
| 123 | MP0003075_altered_response_to | 0.53362759 |
| 124 | MP0002928_abnormal_bile_duct | 0.52706267 |
| 125 | MP0004130_abnormal_muscle_cell | 0.52232519 |
| 126 | MP0005166_decreased_susceptibility_to | 0.51865229 |
| 127 | MP0001756_abnormal_urination | 0.50371311 |
| 128 | MP0005448_abnormal_energy_balance | 0.49707586 |
| 129 | MP0000639_abnormal_adrenal_gland | 0.49578731 |
| 130 | MP0003329_amyloid_beta_deposits | 0.48917318 |
| 131 | MP0001800_abnormal_humoral_immune | 0.48009413 |
| 132 | MP0005395_other_phenotype | 0.47996373 |
| 133 | MP0008874_decreased_physiological_sensi | 0.47235853 |
| 134 | MP0006035_abnormal_mitochondrial_morpho | 0.45156319 |
| 135 | MP0008873_increased_physiological_sensi | 0.44363586 |
| 136 | MP0003638_abnormal_response/metabolism_ | 0.43879648 |
| 137 | MP0000249_abnormal_blood_vessel | 0.43068760 |
| 138 | MP0004947_skin_inflammation | 0.41536312 |
| 139 | MP0002148_abnormal_hypersensitivity_rea | 0.41166891 |
| 140 | MP0003718_maternal_effect | 0.40945451 |
| 141 | MP0004883_abnormal_blood_vessel | 0.39715026 |
| 142 | MP0005248_abnormal_Harderian_gland | 0.38805718 |
| 143 | MP0009053_abnormal_anal_canal | 0.38476130 |
| 144 | MP0005164_abnormal_response_to | 0.38158416 |
| 145 | MP0002723_abnormal_immune_serum | 0.36523563 |
| 146 | MP0001881_abnormal_mammary_gland | 0.35684318 |
| 147 | MP0003953_abnormal_hormone_level | 0.34924172 |
| 148 | MP0002168_other_aberrant_phenotype | 0.34855695 |
| 149 | MP0000579_abnormal_nail_morphology | 0.34811926 |
| 150 | MP0009115_abnormal_fat_cell | 0.34480240 |
| 151 | MP0005000_abnormal_immune_tolerance | 0.34324869 |
| 152 | MP0005058_abnormal_lysosome_morphology | 0.33007024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.26719063 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.19943226 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.16400867 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.79980465 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.54313709 |
| 6 | Xanthomatosis (HP:0000991) | 6.09312962 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.07412655 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.76852479 |
| 9 | Complement deficiency (HP:0004431) | 5.59741472 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 5.58178039 |
| 11 | Genetic anticipation (HP:0003743) | 5.56785539 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.28093787 |
| 13 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 5.14279854 |
| 14 | Joint hemorrhage (HP:0005261) | 5.12530608 |
| 15 | Epidermoid cyst (HP:0200040) | 4.62950158 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.49694532 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.41833236 |
| 18 | Hyperammonemia (HP:0001987) | 4.37776753 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.23748407 |
| 20 | Hyperglycinemia (HP:0002154) | 4.22575611 |
| 21 | Fat malabsorption (HP:0002630) | 4.19670012 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.16955301 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16097297 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13563366 |
| 25 | Abnormality of complement system (HP:0005339) | 4.13244756 |
| 26 | Hyperventilation (HP:0002883) | 4.12260841 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.02155638 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.99387182 |
| 29 | Progressive cerebellar ataxia (HP:0002073) | 3.96939256 |
| 30 | Ketosis (HP:0001946) | 3.94919048 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.90830367 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 3.89749209 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.84855599 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.84855599 |
| 35 | Abnormality of glycolipid metabolism (HP:0010969) | 3.84855599 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 3.83996476 |
| 37 | Hyperglycinuria (HP:0003108) | 3.69833830 |
| 38 | Clumsiness (HP:0002312) | 3.68719681 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 3.68476250 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.68476250 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.59832880 |
| 42 | Hypoglycemic coma (HP:0001325) | 3.58817773 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.52679568 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 3.44709487 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.40319192 |
| 46 | Dysmetric saccades (HP:0000641) | 3.35685691 |
| 47 | Protruding tongue (HP:0010808) | 3.34522014 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 3.34425917 |
| 49 | Myocardial infarction (HP:0001658) | 3.30953434 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 3.26487399 |
| 51 | Optic neuritis (HP:0100653) | 3.26487399 |
| 52 | Steatorrhea (HP:0002570) | 3.23414481 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 3.21169898 |
| 54 | Fair hair (HP:0002286) | 3.17841738 |
| 55 | Hyperbilirubinemia (HP:0002904) | 3.17364484 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.13944374 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.13608605 |
| 58 | Spontaneous abortion (HP:0005268) | 3.10230638 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07597331 |
| 60 | Pancreatic cysts (HP:0001737) | 3.01073908 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 3.00984967 |
| 62 | Abnormality of serum amino acid levels (HP:0003112) | 2.96284663 |
| 63 | Orchitis (HP:0100796) | 2.92597547 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.91134680 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.89307873 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.86811962 |
| 67 | Recurrent abscess formation (HP:0002722) | 2.85367425 |
| 68 | Attenuation of retinal blood vessels (HP:0007843) | 2.73877233 |
| 69 | Congenital sensorineural hearing impairment (HP:0008527) | 2.73469713 |
| 70 | Ketoacidosis (HP:0001993) | 2.72680286 |
| 71 | Stomatitis (HP:0010280) | 2.71969983 |
| 72 | Skin nodule (HP:0200036) | 2.69566643 |
| 73 | Vascular calcification (HP:0004934) | 2.62582319 |
| 74 | Metabolic acidosis (HP:0001942) | 2.62415571 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 2.61702405 |
| 76 | Prostate neoplasm (HP:0100787) | 2.61678581 |
| 77 | Gingival bleeding (HP:0000225) | 2.61573455 |
| 78 | Mitral stenosis (HP:0001718) | 2.61268543 |
| 79 | Generalized hypopigmentation of hair (HP:0011358) | 2.59809397 |
| 80 | Glomerulonephritis (HP:0000099) | 2.58406146 |
| 81 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.54416647 |
| 82 | Abnormality of macrophages (HP:0004311) | 2.46554659 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.46345560 |
| 84 | Acanthocytosis (HP:0001927) | 2.46133103 |
| 85 | Hematochezia (HP:0002573) | 2.41602175 |
| 86 | Myositis (HP:0100614) | 2.40750690 |
| 87 | Lethargy (HP:0001254) | 2.40400635 |
| 88 | Hypoglycemic seizures (HP:0002173) | 2.39131535 |
| 89 | Amyloidosis (HP:0011034) | 2.34694984 |
| 90 | Dicarboxylic aciduria (HP:0003215) | 2.32687243 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.32687243 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30542842 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30542842 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30542842 |
| 95 | Spastic diplegia (HP:0001264) | 2.30417678 |
| 96 | Congenital stationary night blindness (HP:0007642) | 2.30366391 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 2.29646338 |
| 98 | Esophageal varix (HP:0002040) | 2.29645209 |
| 99 | Irritability (HP:0000737) | 2.29610140 |
| 100 | Cardiovascular calcification (HP:0011915) | 2.28998153 |
| 101 | Abnormality of the renal cortex (HP:0011035) | 2.27736957 |
| 102 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27229217 |
| 103 | Abnormality of alanine metabolism (HP:0010916) | 2.27229217 |
| 104 | Hyperalaninemia (HP:0003348) | 2.27229217 |
| 105 | Menorrhagia (HP:0000132) | 2.24531957 |
| 106 | Neonatal onset (HP:0003623) | 2.22880560 |
| 107 | Abolished electroretinogram (ERG) (HP:0000550) | 2.22471060 |
| 108 | Cholelithiasis (HP:0001081) | 2.21375410 |
| 109 | Thrombophlebitis (HP:0004418) | 2.21333771 |
| 110 | Cerebral edema (HP:0002181) | 2.21231105 |
| 111 | Widely spaced teeth (HP:0000687) | 2.20104621 |
| 112 | Mediastinal lymphadenopathy (HP:0100721) | 2.19856174 |
| 113 | Abnormality of the hepatic vasculature (HP:0006707) | 2.17520698 |
| 114 | Pancreatitis (HP:0001733) | 2.16667365 |
| 115 | True hermaphroditism (HP:0010459) | 2.15672138 |
| 116 | Mucopolysacchariduria (HP:0008155) | 2.15535921 |
| 117 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15535921 |
| 118 | Loss of speech (HP:0002371) | 2.15399749 |
| 119 | Gout (HP:0001997) | 2.14077224 |
| 120 | Keratoconjunctivitis sicca (HP:0001097) | 2.12915840 |
| 121 | Keratoconjunctivitis (HP:0001096) | 2.12803495 |
| 122 | Hemorrhage of the eye (HP:0011885) | 2.12723712 |
| 123 | Pancreatic fibrosis (HP:0100732) | 2.10999036 |
| 124 | Absent speech (HP:0001344) | 2.08105003 |
| 125 | Enlarged kidneys (HP:0000105) | 2.07179585 |
| 126 | Sensorimotor neuropathy (HP:0007141) | 2.06757596 |
| 127 | Autoimmune hemolytic anemia (HP:0001890) | 2.06441574 |
| 128 | Inappropriate behavior (HP:0000719) | 2.05781858 |
| 129 | Tubular atrophy (HP:0000092) | 2.05626889 |
| 130 | Abnormality of T cell number (HP:0011839) | 2.05458035 |
| 131 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.04832689 |
| 132 | Chronic hepatic failure (HP:0100626) | 2.03103125 |
| 133 | Febrile seizures (HP:0002373) | 2.02335063 |
| 134 | Generalized aminoaciduria (HP:0002909) | 2.01871706 |
| 135 | Abnormal gallbladder physiology (HP:0012438) | 2.00770584 |
| 136 | Cholecystitis (HP:0001082) | 2.00770584 |
| 137 | Hemoptysis (HP:0002105) | 2.00769486 |
| 138 | Hydroxyprolinuria (HP:0003080) | 2.00765457 |
| 139 | Abnormality of proline metabolism (HP:0010907) | 2.00765457 |
| 140 | Renal cortical cysts (HP:0000803) | 2.00240078 |
| 141 | Hypophosphatemic rickets (HP:0004912) | 1.99710031 |
| 142 | Malnutrition (HP:0004395) | 1.99274582 |
| 143 | Absence seizures (HP:0002121) | 1.98562860 |
| 144 | Dialeptic seizures (HP:0011146) | 1.98547623 |
| 145 | Rickets (HP:0002748) | 1.98114060 |
| 146 | Progressive visual loss (HP:0000529) | 1.96865322 |
| 147 | Opisthotonus (HP:0002179) | 1.96055485 |
| 148 | Disinhibition (HP:0000734) | 1.95888699 |
| 149 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95095498 |
| 150 | Eczematoid dermatitis (HP:0000976) | 1.94950260 |
| 151 | Nephritis (HP:0000123) | 1.94655974 |
| 152 | Abnormality of iron homeostasis (HP:0011031) | 1.93031416 |
| 153 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.92396254 |
| 154 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.91883998 |
| 155 | Abnormality of the periventricular white matter (HP:0002518) | 1.91663405 |
| 156 | Portal hypertension (HP:0001409) | 1.91260548 |
| 157 | Macroglossia (HP:0000158) | 1.91166000 |
| 158 | Abnormality of binocular vision (HP:0011514) | 1.91140594 |
| 159 | Diplopia (HP:0000651) | 1.91140594 |
| 160 | Vomiting (HP:0002013) | 1.90491076 |
| 161 | Facial diplegia (HP:0001349) | 1.89558620 |
| 162 | Alkalosis (HP:0001948) | 1.89362084 |
| 163 | Impaired smooth pursuit (HP:0007772) | 1.89177855 |
| 164 | Poikilocytosis (HP:0004447) | 1.88535255 |
| 165 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88448469 |
| 166 | Decreased circulating renin level (HP:0003351) | 1.87352175 |
| 167 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87264091 |
| 168 | Elevated hepatic transaminases (HP:0002910) | 1.86585899 |
| 169 | Pulmonary embolism (HP:0002204) | 1.86415572 |
| 170 | Macular degeneration (HP:0000608) | 1.86180880 |
| 171 | Abnormality of the gallbladder (HP:0005264) | 1.86102214 |
| 172 | Late onset (HP:0003584) | 1.85924047 |
| 173 | Recurrent skin infections (HP:0001581) | 1.85601685 |
| 174 | Brushfield spots (HP:0001088) | 1.84596319 |
| 175 | Stomach cancer (HP:0012126) | 1.84301914 |
| 176 | Progressive inability to walk (HP:0002505) | 1.83974680 |
| 177 | T lymphocytopenia (HP:0005403) | 1.83361150 |
| 178 | Central scotoma (HP:0000603) | 1.81027160 |
| 179 | Elevated alkaline phosphatase (HP:0003155) | 1.80369070 |
| 180 | Gangrene (HP:0100758) | 1.79918623 |
| 181 | Recurrent fungal infections (HP:0002841) | 1.79643832 |
| 182 | Pulmonary infiltrates (HP:0002113) | 1.76639418 |
| 183 | Cystic liver disease (HP:0006706) | 1.76061167 |
| 184 | Inability to walk (HP:0002540) | 1.75283998 |
| 185 | Arterial thrombosis (HP:0004420) | 1.72916751 |
| 186 | Abnormality of the renal medulla (HP:0100957) | 1.72780904 |
| 187 | Joint swelling (HP:0001386) | 1.71382104 |
| 188 | Vasculitis (HP:0002633) | 1.70582898 |
| 189 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70193097 |
| 190 | Molar tooth sign on MRI (HP:0002419) | 1.69065638 |
| 191 | Abnormality of midbrain morphology (HP:0002418) | 1.69065638 |
| 192 | Furrowed tongue (HP:0000221) | 1.68965997 |
| 193 | Global brain atrophy (HP:0002283) | 1.67268824 |
| 194 | Abnormality of the prostate (HP:0008775) | 1.67035366 |
| 195 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.65171413 |
| 196 | IgA deficiency (HP:0002720) | 1.64775190 |
| 197 | Abnormality of the pericardium (HP:0001697) | 1.62999115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.44877667 |
| 2 | ACVR1B | 4.66602056 |
| 3 | FGFR4 | 4.14400343 |
| 4 | SIK1 | 3.93309839 |
| 5 | ERN1 | 3.85071917 |
| 6 | MAP3K14 | 3.16622247 |
| 7 | TAOK3 | 3.11875172 |
| 8 | INSRR | 2.92487427 |
| 9 | ERBB4 | 2.80829147 |
| 10 | TYK2 | 2.63092584 |
| 11 | BMPR1B | 2.53362078 |
| 12 | BLK | 2.47285154 |
| 13 | GRK7 | 2.06310682 |
| 14 | TBK1 | 2.04505414 |
| 15 | NEK9 | 2.00550391 |
| 16 | MST1R | 1.90208000 |
| 17 | MAP3K13 | 1.84321743 |
| 18 | PBK | 1.80629868 |
| 19 | MAPK11 | 1.75409731 |
| 20 | IRAK3 | 1.68580959 |
| 21 | JAK1 | 1.66961817 |
| 22 | PIK3CG | 1.64003828 |
| 23 | MAP2K4 | 1.61692927 |
| 24 | MATK | 1.57654847 |
| 25 | FLT3 | 1.51590289 |
| 26 | ABL2 | 1.50859080 |
| 27 | OXSR1 | 1.50452928 |
| 28 | TXK | 1.44239740 |
| 29 | JAK2 | 1.38397196 |
| 30 | IKBKE | 1.37641530 |
| 31 | IKBKB | 1.33921808 |
| 32 | DDR2 | 1.32573038 |
| 33 | TRPM7 | 1.26602255 |
| 34 | JAK3 | 1.25457635 |
| 35 | AKT3 | 1.24125056 |
| 36 | PTK6 | 1.24047962 |
| 37 | CSK | 1.18190357 |
| 38 | DAPK2 | 1.16547619 |
| 39 | CSF1R | 1.13477252 |
| 40 | FRK | 1.13086979 |
| 41 | GRK6 | 1.10533153 |
| 42 | EPHB1 | 1.09033303 |
| 43 | PRKAA2 | 1.08044767 |
| 44 | EPHA3 | 1.06577046 |
| 45 | TGFBR1 | 1.05868050 |
| 46 | MAP3K10 | 1.01031251 |
| 47 | MAP3K7 | 1.00917495 |
| 48 | MELK | 0.97169461 |
| 49 | LATS1 | 0.96421054 |
| 50 | CHUK | 0.94331066 |
| 51 | PRKCQ | 0.93964724 |
| 52 | CAMKK2 | 0.93582710 |
| 53 | MAPK4 | 0.93498243 |
| 54 | ADRBK1 | 0.92831022 |
| 55 | PDK2 | 0.90419600 |
| 56 | KDR | 0.89981943 |
| 57 | PKN2 | 0.89546456 |
| 58 | PRKCZ | 0.87342365 |
| 59 | MARK3 | 0.86803874 |
| 60 | MKNK2 | 0.85943123 |
| 61 | PKN1 | 0.85771496 |
| 62 | CDC42BPA | 0.84941795 |
| 63 | IRAK4 | 0.83637971 |
| 64 | ZAK | 0.82493294 |
| 65 | FGFR2 | 0.82313398 |
| 66 | IRAK1 | 0.81817446 |
| 67 | MAP4K1 | 0.80188233 |
| 68 | MAPK12 | 0.75446595 |
| 69 | PIK3CA | 0.74796789 |
| 70 | SYK | 0.74739042 |
| 71 | FGFR3 | 0.74634694 |
| 72 | GRK1 | 0.72597121 |
| 73 | TEC | 0.71914077 |
| 74 | CAMK1G | 0.71542193 |
| 75 | MAP2K3 | 0.70552160 |
| 76 | MAPKAPK3 | 0.69871205 |
| 77 | MAPK15 | 0.69666612 |
| 78 | ERBB2 | 0.69493742 |
| 79 | FER | 0.68824628 |
| 80 | PRKACG | 0.67960095 |
| 81 | PINK1 | 0.66946015 |
| 82 | TNK2 | 0.66710002 |
| 83 | TRIB3 | 0.65760065 |
| 84 | MAP2K6 | 0.63616256 |
| 85 | CDK12 | 0.60856590 |
| 86 | KIT | 0.60840615 |
| 87 | CAMK1D | 0.58507717 |
| 88 | BMPR2 | 0.58265700 |
| 89 | BTK | 0.57126158 |
| 90 | LYN | 0.56559193 |
| 91 | CDK6 | 0.56020389 |
| 92 | SIK2 | 0.55420089 |
| 93 | STK39 | 0.54159147 |
| 94 | CAMK2G | 0.52868189 |
| 95 | MAPK7 | 0.52655416 |
| 96 | IGF1R | 0.52185809 |
| 97 | MAP3K5 | 0.52099894 |
| 98 | LCK | 0.51060724 |
| 99 | NLK | 0.50680471 |
| 100 | RIPK4 | 0.50556776 |
| 101 | IRAK2 | 0.50093084 |
| 102 | PRKAA1 | 0.50067997 |
| 103 | PDPK1 | 0.48975475 |
| 104 | TIE1 | 0.48651004 |
| 105 | HCK | 0.48342389 |
| 106 | DYRK1B | 0.47828807 |
| 107 | STK38L | 0.47481511 |
| 108 | GSK3A | 0.46154287 |
| 109 | ABL1 | 0.45141664 |
| 110 | EIF2AK2 | 0.44748176 |
| 111 | MET | 0.44725523 |
| 112 | TAOK2 | 0.44108934 |
| 113 | NEK6 | 0.43063660 |
| 114 | RPS6KA6 | 0.42548628 |
| 115 | STK4 | 0.42464414 |
| 116 | MAP3K3 | 0.42353453 |
| 117 | PRKCE | 0.41254218 |
| 118 | TGFBR2 | 0.39838354 |
| 119 | SGK3 | 0.39751464 |
| 120 | NUAK1 | 0.39410155 |
| 121 | STK38 | 0.38618534 |
| 122 | PTK2B | 0.38531822 |
| 123 | TLK1 | 0.37430582 |
| 124 | SGK2 | 0.37063210 |
| 125 | ADRBK2 | 0.37016365 |
| 126 | EGFR | 0.36845122 |
| 127 | PIM1 | 0.36839003 |
| 128 | MAPK13 | 0.36410076 |
| 129 | NTRK3 | 0.36179148 |
| 130 | PDK1 | 0.35650689 |
| 131 | RPS6KB2 | 0.34798776 |
| 132 | PDGFRB | 0.34574146 |
| 133 | MAP4K2 | 0.34124881 |
| 134 | PRKCD | 0.33382302 |
| 135 | ITK | 0.32914245 |
| 136 | STK3 | 0.30369776 |
| 137 | MAPKAPK5 | 0.29809302 |
| 138 | MKNK1 | 0.29198475 |
| 139 | CDK4 | 0.28831518 |
| 140 | ZAP70 | 0.28222544 |
| 141 | TYRO3 | 0.27930831 |
| 142 | BMX | 0.27536645 |
| 143 | CAMK4 | 0.26894247 |
| 144 | WNK4 | 0.26611977 |
| 145 | FGR | 0.26440531 |
| 146 | NME2 | 0.24676379 |
| 147 | MAPK3 | 0.24366193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.71335160 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.70651754 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49176895 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31433869 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07958078 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.90729683 |
| 7 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68798991 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59475691 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48618264 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.46932520 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46060390 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39201997 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34037701 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30183975 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20389194 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.20335245 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.19197138 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.13320157 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10661917 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05253073 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.03442913 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01653902 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.99071213 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95737895 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90661574 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88100156 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.87402480 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.86126917 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83641452 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82636663 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81088398 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74984565 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.74831118 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73634777 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72865585 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71407295 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70111245 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69441834 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69341193 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.67073141 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66919817 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.54756442 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50993100 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.48854347 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47908923 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45789846 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.42670014 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38905672 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30179254 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.29167875 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27309220 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26232754 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25587520 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25268935 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24129149 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.23035680 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20983711 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20427878 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18947060 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17339155 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.16167702 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14515312 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13944894 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05538196 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04668369 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03829680 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01970315 |
| 68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00505697 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97693652 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95606571 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93813007 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93805237 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93687703 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91798092 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91695943 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91536340 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90540108 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87591022 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85946263 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85038453 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.84776458 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82784895 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81069217 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.80464455 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79302463 |
| 86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78356990 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75577394 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.74398784 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74276577 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70645062 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64314941 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64203165 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63698174 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62746130 |
| 95 | Phototransduction_Homo sapiens_hsa04744 | 0.62729479 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.62234076 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58523505 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57723648 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57693713 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57655882 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.56318759 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54666086 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52972746 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.52320237 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.50810808 |
| 106 | Taste transduction_Homo sapiens_hsa04742 | 0.50798764 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49630963 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47355132 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44855940 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43589514 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42735738 |
| 112 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42580399 |
| 113 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.42552461 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.42348268 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42240123 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42071227 |
| 117 | Nicotine addiction_Homo sapiens_hsa05033 | 0.41686950 |
| 118 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.40658754 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.39900635 |
| 120 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39691985 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39597047 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39143072 |
| 123 | Salivary secretion_Homo sapiens_hsa04970 | 0.38997970 |
| 124 | Homologous recombination_Homo sapiens_hsa03440 | 0.38942293 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27056636 |
| 126 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22835507 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.21029562 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17091614 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15474197 |
| 130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13431725 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.12943554 |
| 132 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11989280 |
| 133 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.10513463 |
| 134 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.09283609 |
| 135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08754884 |
| 136 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.07235234 |
| 137 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.04104404 |
| 138 | Allograft rejection_Homo sapiens_hsa05330 | 0.00998238 |
| 139 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.00657215 |
| 140 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1479288 |
| 141 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1426549 |
| 142 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1423844 |
| 143 | Leishmaniasis_Homo sapiens_hsa05140 | -0.1422361 |
| 144 | Legionellosis_Homo sapiens_hsa05134 | -0.1208291 |
| 145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1200818 |
| 146 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1184819 |
| 147 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.1165253 |
| 148 | Malaria_Homo sapiens_hsa05144 | -0.1128386 |
| 149 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1063315 |
| 150 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0797780 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0781686 |
| 152 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0744470 |
| 153 | Hepatitis C_Homo sapiens_hsa05160 | -0.0502698 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0191915 |
| 155 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0028835 |
| 156 | Pertussis_Homo sapiens_hsa05133 | -0.0011217 |

